Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
6,400
Employees6,400
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
6,400
Employees6,400

VRTX Key Statistics

Market cap
110.77B
Market cap110.77B
Price-Earnings ratio
28.83
Price-Earnings ratio28.83
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
$445.34
High today$445.34
Low today
$431.15
Low today$431.15
Open price
$442.35
Open price$442.35
Volume
950.51K
Volume950.51K
52 Week high
$510.77
52 Week high$510.77
52 Week low
$362.50
52 Week low$362.50

Stock Snapshot

As of today, Vertex Pharmaceuticals(VRTX) shares are valued at $435.50. The company's market cap stands at 110.77B, with a P/E ratio of 28.83.

As of 2026-04-16, Vertex Pharmaceuticals(VRTX) stock has fluctuated between $431.15 and $445.34. The current price stands at $435.50, placing the stock +1.0% above today's low and -2.2% off the high.

The Vertex Pharmaceuticals(VRTX)'s current trading volume is 950.51K, compared to an average daily volume of 1.16M.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $510.77 at its peak.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $510.77 at its peak.

VRTX News

The Motley Fool 32m
Is Vertex Pharmaceuticals' Empire in Trouble?

Over the past 10 years, Vertex Pharmaceuticals (VRTX 1.91%) has delivered market-beating returns. The company owes this performance to its dominance in the cyst...

Is Vertex Pharmaceuticals' Empire in Trouble?
TipRanks 1d
Vertex Pharmaceuticals: Solid CF Franchise and Emerging Pipeline Support Buy Rating and Premium Valuation

Tazeen Ahmad, an analyst from Bank of America Securities, reiterated the Buy rating on Vertex Pharmaceuticals. The associated price target remains the same with...

The Motley Fool 3d
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.

Gas prices have soared roughly 80% year to date. When transportation costs rise, so do the prices of most products. Federal Reserve Chair Jerome Powell publicly...

Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.

Analyst ratings

77%

of 35 ratings
Buy
77.1%
Hold
17.1%
Sell
5.7%

More VRTX News

Simply Wall St 5d
Is It Time To Revisit Vertex Pharmaceuticals After The Recent Share Price Pullback?

If you are wondering whether Vertex Pharmaceuticals at around US$436 a share is offering value or asking you to pay up for quality, this article will help you f...

Is It Time To Revisit Vertex Pharmaceuticals After The Recent Share Price Pullback?
Nasdaq 6d
Vertex Pharmaceuticals Dips More Than Broader Market: What You Should Know

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing...

Vertex Pharmaceuticals Dips More Than Broader Market: What You Should Know

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.